受强制性开放获取政策约束的文章 - Richard F. Riedel, MD了解详情
无法在其他位置公开访问的文章：1 篇
Soft tissue sarcoma
GD Demetri, S Antonia, RS Benjamin, MM Bui, ES Casper, EU Conrad, ...
Journal of the National Comprehensive Cancer Network 8 (6), 630-674, 2010
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：30 篇
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
GD Demetri, M Von Mehren, CR Antonescu, RP DeMatteo, KN Ganjoo, ...
Journal of the National Comprehensive Cancer Network 8 (Suppl_2), S-1-S-41, 2010
强制性开放获取政策： US National Institutes of Health
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ...
The Lancet Oncology 18 (11), 1493-1501, 2017
强制性开放获取政策： US National Institutes of Health
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
强制性开放获取政策： US National Institutes of Health
Sorafenib for advanced and refractory desmoid tumors
MM Gounder, MR Mahoney, BA Van Tine, V Ravi, S Attia, HA Deshpande, ...
New England Journal of Medicine 379 (25), 2417-2428, 2018
强制性开放获取政策： US National Institutes of Health
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre …
WD Tap, Z Papai, BA Van Tine, S Attia, KN Ganjoo, RL Jones, S Schuetze, ...
The lancet oncology 18 (8), 1089-1103, 2017
强制性开放获取政策： US National Institutes of Health
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
MJ Whitley, DM Cardona, AL Lazarides, I Spasojevic, JM Ferrer, J Cahill, ...
Science translational medicine 8 (320), 320ra4-320ra4, 2016
强制性开放获取政策： US National Institutes of Health
Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma
LE Davis, V Bolejack, CW Ryan, KN Ganjoo, ET Loggers, S Chawla, ...
Journal of Clinical Oncology 37 (16), 1424-1431, 2019
强制性开放获取政策： US National Institutes of Health
Effects of enhanced caregiver training program on cancer caregiver’s self-efficacy, preparedness, and psychological well-being
CC Hendrix, DE Bailey, KE Steinhauser, MK Olsen, KM Stechuchak, ...
Supportive Care in Cancer 24, 327-336, 2016
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs
Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology
M von Mehren, JM Kane, M Agulnik, MM Bui, J Carr-Ascher, E Choy, ...
Journal of the National Comprehensive Cancer Network 20 (7), 815-833, 2022
强制性开放获取政策： US National Institutes of Health
Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab
EZ Keung, M Burgess, R Salazar, ER Parra, J Rodrigues-Canales, ...
Clinical Cancer Research 26 (6), 1258-1266, 2020
强制性开放获取政策： US National Institutes of Health
Nirogacestat, a γ-secretase inhibitor for desmoid tumors
M Gounder, R Ratan, T Alcindor, P Schöffski, WT Van Der Graaf, BA Wilky, ...
New England Journal of Medicine 388 (10), 898-912, 2023
强制性开放获取政策： US National Institutes of Health
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
AJ Wagner, V Ravi, RF Riedel, K Ganjoo, BA Van Tine, R Chugh, ...
Journal of Clinical Oncology 39 (33), 3660-3670, 2021
强制性开放获取政策： US National Institutes of Health
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma
JK Mito, RF Riedel, L Dodd, G Lahat, AJ Lazar, RD Dodd, L Stangenberg, ...
PloS one 4 (11), e8075, 2009
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute
Characterizing the developmental pathways TTF-1, NKX2–8, and PAX9 in lung cancer
DS Hsu, CR Acharya, BS Balakumaran, RF Riedel, MK Kim, M Stevenson, ...
Proceedings of the National Academy of Sciences 106 (13), 5312-5317, 2009
强制性开放获取政策： US National Institutes of Health
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022: Featured Updates to the NCCN Guidelines
M von Mehren, JM Kane, RF Riedel, JK Sicklick, SM Pollack, M Agulnik, ...
Journal of the National Comprehensive Cancer Network 20 (11), 1204-1214, 2022
强制性开放获取政策： US National Institutes of Health
Atezolizumab for advanced alveolar soft part sarcoma
AP Chen, E Sharon, G O’Sullivan-Coyne, N Moore, JC Foster, JS Hu, ...
New England Journal of Medicine 389 (10), 911-921, 2023
强制性开放获取政策： US National Institutes of Health
Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma
AJ Wisdom, YM Mowery, RF Riedel, DG Kirsch
Cancer 124 (19), 3819-3829, 2018
强制性开放获取政策： US National Institutes of Health
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
G Vlahovic, KL Meadows, HE Uronis, MA Morse, GC Blobe, RF Riedel, ...
Cancer chemotherapy and pharmacology 70, 95-102, 2012
强制性开放获取政策： US National Institutes of Health
Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial
MM Gounder, AA Razak, N Somaiah, S Chawla, J Martin-Broto, ...
Journal of Clinical Oncology 40 (22), 2479-2490, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定